Millions of Seniors Unaware of significant Valvular Heart Disease
Table of Contents
Results from the PREVUE-VALVE study indicate that at least 4.7 million Americans aged 65-85 are living with moderate or greater valvular heart disease (VHD), and at least 10.6 million have clinically significant VHD – a condition most are unaware of. The prevalence of VHD rises dramatically with age, highlighting the need for increased screening and treatment access.
These findings were presented at TCT® 2025, the annual scientific symposium of the Cardiovascular Research Foundation® (CRF®), a leading educational meeting in interventional cardiovascular medicine.
Understanding Valvular Heart Disease
Valvular heart disease occurs when one or more of the heart valves don’t function properly. This can lead to a variety of symptoms, but many patients experience none at all, delaying diagnosis and treatment. The incidence of VHD is growing in the U.S. and globally. The American Heart Association reports that nearly 25,000 americans die from VHD annually.
The PREVUE-VALVE Study: Key Findings
The PREVUE-VALVE study involved recruiting older adults (ages 65-85) from retail pharmacies across the United States. after initial screening, 3,000 participants received at-home visits including a 12-lead electrocardiogram and a formal echocardiogram.
Study Methodology
- Participant Recruitment: individuals aged 65-85 were recruited from retail pharmacies nationwide.
- Initial Screening: Participants underwent a preliminary screening process.
- At-Home Evaluation: A subset of 3,000 participants received in-home assessments.
- Diagnostic Tests: Evaluations included a 12-lead electrocardiogram and a formal echocardiogram.
Why Early Detection Matters
Early detection of VHD is crucial for several reasons:
- Improved Treatment Outcomes: Timely intervention can considerably improve quality of life and survival rates.
- Preventing complications: Untreated VHD can lead to heart failure, stroke, and other serious health problems.
- Increased Awareness: Raising awareness about VHD can empower individuals to seek medical attention if they experience symptoms.
Frequently Asked Questions (FAQ)
Q: What are the common symptoms of VHD?
A: Common symptoms include shortness of breath, fatigue, dizziness, chest pain, and swelling in the ankles and feet. Though, many people with VHD experience no symptoms at all.
Q: How is VHD diagnosed?
A: VHD is typically diagnosed through a physical exam, echocardiogram, and potentially other imaging tests.
Q: What are the treatment options for VHD?
A: Treatment options vary depending on the severity of the condition and may include medication, lifestyle changes, or surgery to repair or replace the affected valve.
Key Takeaways
- A significant number of seniors in the U.S. have undiagnosed valvular heart disease.
- the prevalence of VHD increases with age.
- Early detection and treatment are essential for improving outcomes.
- Increased screening programs are needed to reach those unaware of their condition.
Publication Date: 2025/10/28 04:21:19